Found: 15
Select item for more details and to access through your institution.
The evolving landscape of COVID‐19 and post‐COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLL.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 12, p. 1856, doi. 10.1002/ajh.27093
- By:
- Publication type:
- Article
Results of ARI‐0001 CART19 cell therapy in patients with relapsed/refractory CD19‐positive acute lymphoblastic leukemia with isolated extramedullary disease.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 6, p. 731, doi. 10.1002/ajh.26519
- By:
- Publication type:
- Article
Predictive factors for anemia response to erythropoiesis-stimulating agents in myelofibrosis.
- Published in:
- European Journal of Haematology, 2017, v. 98, n. 4, p. 407, doi. 10.1111/ejh.12846
- By:
- Publication type:
- Article
Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and severe COVID-19: a study of ERIC, the European Research Initiative on CLL.
- Published in:
- Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01333-0
- By:
- Publication type:
- Article
Clinical characteristics, prognosis and treatment of myelofibrosis patients with severe thrombocytopenia.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Detection of inflammatory monocytes but not mesenchymal stem/stromal cells in peripheral blood of patients with myelofibrosis.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Age and comorbidity are determining factors in the overall and relative survival of patients with follicular lymphoma.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Genomic characterization in triple-negative primary myelofibrosis and other myeloid neoplasms with bone marrow fibrosis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Prognostic risk models for transplant decision-making in myelofibrosis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Imatinib dose reduction in patients with chronic myeloid leukemia in sustained deep molecular response.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Danazol therapy for the anemia of myelofibrosis: assessment of efficacy with current criteria of response and long-term results.
- Published in:
- 2015
- By:
- Publication type:
- journal article
A low total metabolic tumor volume independently predicts for a longer time to first treatment in initially observed, low tumor burden follicular lymphoma.
- Published in:
- Hematological Oncology, 2024, v. 42, n. 1, p. 1, doi. 10.1002/hon.3235
- By:
- Publication type:
- Article
Serum soluble CD23 levels are an independent predictor of time to first treatment in chronic lymphocytic leukemia.
- Published in:
- Hematological Oncology, 2022, v. 40, n. 4, p. 588, doi. 10.1002/hon.3027
- By:
- Publication type:
- Article
First external validation of the FLIPI‐L score in a single‐center series of patients with follicular lymphoma.
- Published in:
- Hematological Oncology, 2022, v. 40, n. 2, p. 297, doi. 10.1002/hon.2953
- By:
- Publication type:
- Article
Prognostic ability of five clinical risk scores in follicular lymphoma: A single‐center evaluation.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 5, p. 639, doi. 10.1002/hon.2922
- By:
- Publication type:
- Article